agilon health receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
agilon health Inc (AGL)
agilon health Inc stock price live, this page displays NYSE AGL stock exchange data. View the AGL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the agilon health Inc real time stock price chart below.
What Is the agilon health Inc Stock Price Today?
The agilon health Inc stock price today is 96.78.
What Is the Stock Symbol for agilon health Inc?
The stock symbol for agilon health Inc is "AGL."
What Stock Exchange Does agilon health Inc Trade On?
agilon health Inc is listed and trades on the NYSE stock exchange.
Is agilon health Inc a Good Stock to Buy?
Determining whether agilon health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGL quote. (ISIN: US00857U2069)
What Is the agilon health Inc Stock Price Today?
The agilon health Inc stock price today is 96.78.
What Is the Stock Symbol for agilon health Inc?
The stock symbol for agilon health Inc is "AGL."
What Stock Exchange Does agilon health Inc Trade On?
agilon health Inc is listed and trades on the NYSE stock exchange.
Is agilon health Inc a Good Stock to Buy?
Determining whether agilon health Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGL quote. (ISIN: US00857U2069)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.56
103.88
52 wk Range
7.48
133.04
AGL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
94.56103.88
52 wk Range
7.48133.04
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AGL Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
109.77
Upside
+13.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
agilon health receives Investment Bank Analyst Rating Update- Investing.com
Pro
- agilon health receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- agilon health receives Investment Bank Analyst Rating Update
- Investing.com
Pro - agilon health receives Investment Bank Analyst Rating Update
- Investing.com
Pro - agilon health receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
agilon health receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
10 Hold
2 Sell
Ratings:
16 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 109.77
(+13.42% Upside)
agilon health Inc SWOT Analysis
Profitability Push | Agilon Health pivots from rapid growth to profitability amid challenging financial results, including revenue decline and EBITDA losses in Q2 2025 |
Leadership Transition | CEO departure triggers strategic reevaluation, with focus shifting to operational efficiency and improved financial performance under interim leadership |
Market Headwinds | Explore how medical cost pressures, declining membership, and cash burn impact Agilon's path to positive cash flow, projected for 2027 |
Analyst Outlook | Price targets range from $2 to $3, reflecting cautious market sentiment as Agilon navigates profitability challenges in the Medicare Advantage secto |
agilon health Inc Earnings Call Summary for Q2/2026
- Agilon Health reported Q2 2026 EPS of $1.04, beating estimates by $0.96, with revenue of $1.49B topping forecasts by $50M amid 7.1% YoY growth.
- Medical margin surged to $197M from negative $53M YoY; adjusted EBITDA reached $70M versus negative $83M, driven by risk adjustment and cost improvements.
- Company raised FY2026 guidance to ~$5.8B revenue, ~$485M medical margin, and ~$85M adjusted EBITDA despite intentional 12.3% membership decline.
- Shares jumped 13.79% to $107.85, adding 1.92% after-hours; stock has gained 500% over six months as strategic contracting discipline improves profitability.
- Management expects 7% medical cost trends in H2 2026, with risk adjustment benefits continuing into 2027 though at lower levels than current year.
Last Updated: 08/06/2026, 05:40 AM
Read Full TranscriptEarnings
Latest Release
Aug 05, 2026
EPS / Forecast
1.04 / 0.08
Revenue / Forecast
1.49B / 1.44B
Compare AGL to Peers and Sector
Metrics to compare | AGL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAGLPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.5x | 19.6x | −0.4x | |
PEG Ratio | −0.24 | 0.47 | 0.00 | |
Price/Book | 7.1x | 2.9x | 2.6x | |
Price / LTM Sales | 0.3x | 1.1x | 3.1x | |
Upside (Analyst Target) | 17.8% | 38.6% | 48.2% | |
Fair Value Upside | Unlock | 17.0% | 5.8% | Unlock |
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the agilon health (AGL) Stock Price Today?
The agilon health stock price today is 96.78 USD.
What Stock Exchange Does agilon health Trade On?
agilon health is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for agilon health?
The stock symbol for agilon health is "AGL."
What Is the agilon health Market Cap?
As of today, agilon health market cap is 1.63B USD.
What Is agilon health's Earnings Per Share (TTM)?
The agilon health EPS (TTM) is -15.12.
When Is the Next agilon health Earnings Date?
agilon health will release its next earnings report on Oct 29, 2026.
From a Technical Analysis Perspective, Is AGL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has agilon health Stock Split?
agilon health has split 1 times.
How Many Employees Does agilon health Have?
agilon health has 856 employees.
What is the current trading status of agilon health (AGL)?
As of Aug 11, 2026, agilon health (AGL) is trading at a price of 96.78 USD, with a previous close of 96.78 USD. The stock has fluctuated within a day range of 94.56 USD to 103.88 USD, while its 52-week range spans from 7.48 USD to 133.04 USD.
What Is agilon health (AGL) Price Target According to Analysts?
The average 12-month price target for agilon health is 109.77 USD, with a high estimate of 141 USD and a low estimate of 31 USD. 4 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +13.42% Upside potential.
What Is the AGL Premarket Price?
AGL's last pre-market stock price is 95.70 USD. The pre-market share volume is 100.00, and the stock has decreased by 0.19, or 0.20%.
What Is the AGL After Hours Price?
AGL's last after hours stock price is 98.00 USD, the stock has decreased by 1.22, or 1.26%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.